1987
DOI: 10.1016/s0002-9378(87)80178-3
|View full text |Cite
|
Sign up to set email alerts
|

A study on intrauterine fetal resuscitation with terbutaline

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1
1

Citation Types

0
25
1
2

Year Published

1995
1995
2018
2018

Publication Types

Select...
7
2

Relationship

0
9

Authors

Journals

citations
Cited by 35 publications
(28 citation statements)
references
References 6 publications
0
25
1
2
Order By: Relevance
“…10 Tocolysis is rarely used currently because clinicians assume that the origin of the fetal dis-tress arises in the placenta. If, as suggested by these data, myometrial contractility were a factor in fetal distress, then further consideration should be given to tocolysis using b 2 -sympathomimetics, [16][17][18][19] magnesium sulphate 20 or nitroglycerin. [19][20][21][22]…”
Section: Discussionmentioning
confidence: 99%
“…10 Tocolysis is rarely used currently because clinicians assume that the origin of the fetal dis-tress arises in the placenta. If, as suggested by these data, myometrial contractility were a factor in fetal distress, then further consideration should be given to tocolysis using b 2 -sympathomimetics, [16][17][18][19] magnesium sulphate 20 or nitroglycerin. [19][20][21][22]…”
Section: Discussionmentioning
confidence: 99%
“…No extraña pues, que al producir una relajación uterina farmacológica, el feto pueda recuperar su estado de oxemia basal y mejorar así las alteraciones que se produzcan en el MEFI. Hay suficiente evidencia para afirmar que la tocolisis intraparto, es una maniobra de resucitación intrauterina efectiva, en mejorar las alteraciones del MEFI con una efectividad promedio cercana al 80% (27)(28)(29). Esta efectividad está claramente demostrada para ß-miméticos y Nitroglicerina, no existiendo estudios suficientes que confirmen a Atosiban como tocolí-tico efectivo para resucitación intrauterina frente a un MEFI alterado.…”
Section: Discussionunclassified
“…En 1998, Kulier y Hofmeyr (26), llevaron a cabo una revisión sistemática en la base de datos Cochrane, considerando 3 estudios randomizados controlados que utilizaron ß-miméticos como maniobra de resucitación intrauterina. El primer estudio (27), comparó Terbutalina vs no tratamiento, mejorando el MEFI en el 91% de las pacientes tratadas con Terbutalina y 0% en el grupo de no tratamiento (RR 11,11; IC 95% 1,7-100). El segundo estudio (28), comparó Terbutalina vs Sulfato de Magnesio, logrando mejoría del MEFI en 91,3% de las pacientes tratadas con Terbutalina y 69,6% de las pacientes tratadas con Sulfato de Magnesio.…”
Section: Tocolisis Inrapartounclassified
“…Although hexoprenaline seemed to improve the blood gas values and reduced the uterine activity, the small sample size and absence of a control group does not allow conclusions to be drawn. PATRIARCO et al [7] randomised patients with persistent fetal heart rate changes and fetal scalp blood pH of less than 7.25 to a terbutaline-treated or control group. In the terbutaline group, Apgar scores were more likely to be higher and fewer babies were acidotic.…”
Section: Discussionmentioning
confidence: 99%